Marex Group’s Thermo Fisher Scientific TMO Stock Holding History

Marex Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	2,266 -142	-6%	-$68.2K	﹤0.01%	477
2026 Q1	$1.18M	Buy	2,408 +1,125	+88%	+$611K	0.01%	412
2025 Q4	$743K	Sell	1,283 -80,147	-98%	-$45.3M	﹤0.01%	458
2025 Q3	$39.5M	Sell	81,430 -19,006	-19%	-$8.85M	0.28%	73
2025 Q2	$40.7M	Sell	100,436 -21,418	-18%	-$8.96M	0.35%	66
2025 Q1	$60.6M	Buy	121,854 +914	+0.8%	+$495K	1.16%	23
2024 Q4	$62.9M	Buy	120,940 +916	+0.8%	+$504K	1.07%	21
2024 Q3	$74.2M	Buy	120,024 +8	+0%	+$4.74K	1.69%	16
2024 Q2	$66.4M	Sell	120,016 -2,484	-2%	-$1.42M	1.78%	10
2024 Q1	$71.2M	Buy	+122,500	New	+$68.7M	2.31%	9
2023 Q1	–	Sell	-10,137	Closed	-$5.65M	–	328
2022 Q4	$5.65M	Buy	+10,137	New	+$5.37M	0.8%	23

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Marex Group's TMO Position: Q2 2026 in Review

Marex Group reduced its Thermo Fisher Scientific (TMO) stake by 5.9% in Q2 2026, selling an estimated $68.2K and leaving 2,266 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Marex Group first reported a position in TMO in Q4 2022 and has held it in 11 quarters since. The position peaked at $74.2M in Q3 2024. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Marex Group held 2,266 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
Marex Group sold 142 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.2K.
Thermo Fisher Scientific made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #477 holding.
Marex Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 11 quarters since.
Marex Group's Thermo Fisher Scientific position peaked at $74.2M in Q3 2024.
2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.